Prolonged incubation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a patient on rituximab therapy
Alan Koff, Maudry Laurent-Rolle, Jack Chun-Chieh Hsu, Maricar Malinis
Abstract
The incubation period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rarely >14 days. We report a patient with hypogammaglobulinemia who developed coronavirus disease 2019 (COVID-19) with a confirmed incubation period of at least 21 days. These findings raise concern for a prolonged presymptomatic transmission phase, necessitating a longer quarantine duration in this patient population.
Topics & Concepts
MedicineIncubation periodCoronavirusCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)HypogammaglobulinemiaIncubationRespiratory diseaseRespiratory systemSevere acute respiratory syndromeQuarantinePopulationImmunologyInternal medicineDiseaseAntibodyInfectious disease (medical specialty)LungPathologyBiologyEnvironmental healthBiochemistryCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchImmunodeficiency and Autoimmune Disorders